Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma
暂无分享,去创建一个
[1] E. Thompson,et al. Doxycycline-Inducible Expression of SPARC/ Osteonectin/ BM40 in MDA-MB-231 Human Breast Cancer Cells Results in Growth Inhibition , 2002, Breast Cancer Research and Treatment.
[2] I. Kalajzic,et al. Osteonectin-null mutation compromises osteoblast formation, maturation, and survival. , 2003, Endocrinology.
[3] R. Hynes,et al. Physiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin. , 2003, Cancer cell.
[4] R. Brekken,et al. Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM. , 2003, The Journal of clinical investigation.
[5] M. Reed,et al. Compromised production of extracellular matrix in mice lacking secreted protein, acidic and rich in cysteine (SPARC) leads to a reduced foreign body reaction to implanted biomaterials. , 2003, The American journal of pathology.
[6] M. Nishimura,et al. Increasing tumor antigen expression overcomes "ignorance" to solid tumors via crosspresentation by bone marrow-derived stromal cells. , 2002, Immunity.
[7] G. Fleuren,et al. Transforming growth factor-beta1 induces tumor stroma and reduces tumor infiltrate in cervical cancer. , 2002, Human pathology.
[8] N. Lemke,et al. Secreted protein acidic and rich in cysteine promotes glioma invasion and delays tumor growth in vivo. , 2002, Cancer research.
[9] I. Fidler,et al. Contributions of stromal metalloproteinase-9 to angiogenesis and growth of human ovarian carcinoma in mice. , 2002, Journal of the National Cancer Institute.
[10] John I. Clark,et al. Alterations in the lens capsule contribute to cataractogenesis in SPARC-null mice. , 2002, Journal of cell science.
[11] Zena Werb,et al. Stromal Effects on Mammary Gland Development and Breast Cancer , 2002, Science.
[12] G. Schuler,et al. Matrix Metalloproteinases 9 and 2 Are Necessary for the Migration of Langerhans Cells and Dermal Dendritic Cells from Human and Murine Skin1 , 2002, The Journal of Immunology.
[13] M. Ringuette,et al. Evolutionary conservation and association of SPARC with the basal lamina in Drosophila , 2002, Development Genes and Evolution.
[14] R. Berkowitz,et al. SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells. , 2001, The American journal of pathology.
[15] E. Sage,et al. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. , 2001, The Journal of clinical investigation.
[16] Andrew V. Nguyen,et al. Colony-Stimulating Factor 1 Promotes Progression of Mammary Tumors to Malignancy , 2001, The Journal of experimental medicine.
[17] Alberto Mantovani,et al. Inflammation and cancer: back to Virchow? , 2001, The Lancet.
[18] P. Musiani,et al. The intriguing role of polymorphonuclear neutrophils in antitumor reactions. , 2001, Blood.
[19] L. Coussens,et al. Inflammatory Cells and Cancer: Think Different! , 2001 .
[20] K. Miyazaki,et al. Abnormal distribution of collagen type IV in extrahepatic bile duct carcinoma , 2000, Pathology international.
[21] D. Hanahan,et al. MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.
[22] L. Camardella,et al. Trimer Carboxyl Propeptide of Collagen I Produced by Mature Osteoblasts Is Chemotactic for Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[23] J. Tonn,et al. Targeting angiogenesis inhibits tumor infiltration and expression of the pro‐invasive protein SPARC , 2000, International journal of cancer.
[24] M. Amling,et al. Osteopenia and decreased bone formation in osteonectin-deficient mice , 2000, The Journal of clinical investigation.
[25] M. Castellazzi,et al. Down-regulation of the extracellular matrix protein SPARC in vSrc- and vJun-transformed chick embryo fibroblasts contributes to tumor formation in vivo , 2000, Oncogene.
[26] G. Fantuzzi,et al. IL-18 regulates IL-1beta-dependent hepatic melanoma metastasis via vascular cell adhesion molecule-1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[27] E. Sage,et al. SPARC, a Matricellular Glycoprotein with Important Biological Functions , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[28] W. Couser,et al. SPARC Regulates the Expression of Collagen Type I and Transforming Growth Factor-β1 in Mesangial Cells* , 1999, The Journal of Biological Chemistry.
[29] P. Musiani,et al. Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin. , 1999, Laboratory investigation; a journal of technical methods and pathology.
[30] G. Yancopoulos,et al. New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF , 1999, Oncogene.
[31] T. Mikkelsen,et al. Increased SPARC expression promotes U87 glioblastoma invasion in vitro , 1999, International Journal of Developmental Neuroscience.
[32] G. Kollias,et al. Mice deficient in tumor necrosis factor-α are resistant to skin carcinogenesis , 1999, Nature Medicine.
[33] C C Howe,et al. Disruption of the Sparc locus in mice alters the differentiation of lenticular epithelial cells and leads to cataract formation. , 1999, Experimental eye research.
[34] S. Rempel,et al. SPARC: a potential diagnostic marker of invasive meningiomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] E. Sage,et al. SPARC deficiency leads to early-onset cataractogenesis. , 1998, Investigative ophthalmology & visual science.
[36] E. Sage,et al. SPARC (BM-40, Osteonectin) Inhibits the Mitogenic Effect of Vascular Endothelial Growth Factor on Microvascular Endothelial Cells* , 1998, The Journal of Biological Chemistry.
[37] D. Hanahan,et al. Tumor microenvironment can restrict the effectiveness of activated antitumor lymphocytes. , 1998, Cancer research.
[38] Piero Musiani,et al. Interleukin 12–mediated Prevention of Spontaneous Mammary Adenocarcinomas in Two Lines of Her-2/neu Transgenic Mice , 1998, The Journal of experimental medicine.
[39] J. Sanes,et al. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age‐onset cataract formation and disruption of the lens , 1998, The EMBO journal.
[40] Gomes Mc. Population aging and forms of residence in Mexico , 1997 .
[41] R. Timpl,et al. Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: characterization of the binding of vitronectin to osteonectin (BM40, SPARC). , 1997, The Biochemical journal.
[42] O. Podhajcer,et al. Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells , 1997, Nature Medicine.
[43] E. Sage. Terms of attachment: SPARC and tumorigenesis , 1997, Nature Medicine.
[44] R. Berkowitz,et al. SPARC, an extracellular matrix protein with tumor-suppressing activity in human ovarian epithelial cells. , 1996, Oncogene.
[45] W. Wiktor-Jedrzejczak,et al. Impaired tumor growth in colony‐stimulating factor 1 (CSF‐1)‐deficient, macrophage‐deficient op/op mouse: Evidence for a role of CSF‐1‐dependent macrophages in formation of tumor stroma , 1996, International journal of cancer.
[46] S. Hauser,et al. Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.
[47] E. Waubant,et al. T cell gelatinases mediate basement membrane transmigration in vitro. , 1995, Journal of immunology.
[48] P. Vernier,et al. SPARC and thrombospondin genes are repressed by the c‐jun oncogene in rat embryo fibroblasts. , 1994, The EMBO journal.
[49] R. Berkowitz,et al. Molecular cloning of differentially expressed genes in human epithelial ovarian cancer. , 1994, Gynecologic oncology.
[50] M. Colombo,et al. Regression of an established tumor genetically modified to release granulocyte colony-stimulating factor requires granulocyte-T cell cooperation and T cell-produced interferon gamma , 1993, The Journal of experimental medicine.
[51] E. Sage,et al. SPARC antagonizes the effect of basic fibroblast growth factor on the igration of bovine aortic endothelial cells , 1992, Journal of cellular biochemistry.
[52] R. Ross,et al. The extracellular glycoprotein SPARC interacts with platelet-derived growth factor (PDGF)-AB and -BB and inhibits the binding of PDGF to its receptors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[53] R. Timpl,et al. Calcium-dependent binding of basement membrane protein BM-40 (osteonectin, SPARC) to basement membrane collagen type IV. , 1991, European journal of biochemistry.
[54] M. Iruela-Arispe,et al. Differential expression of extracellular proteins is correlated with angiogenesis in vitro. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[55] M. Colombo,et al. Down-regulation of SPARC/osteonectin/BM-40 expression in methylcholanthrene-induced fibrosarcomas and in Kirsten-MSV transformed fibroblasts. , 1991, European journal of cancer.
[56] W. Wiktor-Jedrzejczak,et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[57] S. Nishikawa,et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene , 1990, Nature.
[58] P. Delmas,et al. Complex formation of human thrombospondin with osteonectin. , 1988, European journal of biochemistry.
[59] B. Hogan,et al. Molecular analysis of the cDNA for human SPARC/osteonectin/BM-40: sequence, expression, and localization of the gene to chromosome 5q31-q33. , 1988, Genomics.
[60] S. Segal,et al. An immune response against the alloantigens of the 3LL Lewis lung carcinoma prevents the growth of lung metastases, but not of local allografts. , 1982, Invasion and Metastasis.
[61] I. Gresser,et al. Inhibition by interferon preparations of a solid malignant tumour and pulmonary metastasis in mice. , 1972, Nature: New biology.
[62] A. Zuckerman,et al. Australia Antigen as a Marker of Propagation of the Serum Hepatitis Virus in Liver Cultures , 1972, Nature.
[63] G. Sheline,et al. THE ELIMINATION OF ADMINISTERED ZINC IN PANCREATIC JUICE, DUODENAL JUICE, AND BILE OF THE DOG AS MEASURED BY ITS RADIOACTIVE ISOTOPE (Zn65) , 1943, Journal of Experimental Medicine.
[64] James Gane. CASE OF CHOLERA SPASMODICA, TENDING TO PROVE THE EXISTENCE OF AN EPIDEMIC DISEASE IN ENGLAND,: SIMILAR TO THE INDIAN CHOLERA, BUT ENTIRELY UNCONNECTED WITH THAT PESTILENCE , 1832 .